The US Food and Drug Administration (FDA) plans to restrict its approval process for updated Covid-19 shots primarily targeting older adults and individuals at high risk of severe illness, according to the agency’s head as outlined in a recent medical journal article.
Source: https://www.barrons.com/articles/moderna-stock-price-fda-covid-shots-dba688e6